West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Free Cash Flow Yield: 1.80%

Is the free cash flow yield high or low?

The free cash flow yield of 1.80% is 11% above its 5-year average of 1.62%, around the middle of its 5-year range (0.81%–2.79%).

As of Sunday, June 28, 2026. 7.61% below its 12-month average of 1.95%.

WST Free Cash Flow Yield

WST Free Cash Flow Yield Chart

1.80%
-6.25% 1Y
WST Free Cash Flow Yield

WST Average Free Cash Flow Yield Chart

WST Free Cash Flow Yield

WST Current vs Average Free Cash Flow Yield Chart

WST Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

1.80%

FREE CASH FLOW YIELD AVG TTM

1.95%

FREE CASH FLOW YIELD AVG 3Y

1.69%

FREE CASH FLOW YIELD AVG 5Y

1.61%

FREE CASH FLOW YIELD AVG 10Y

1.60%

FREE CASH FLOW YIELD AVG 15Y

1.67%

FREE CASH FLOW YIELD AVG 20Y

1.74%

CURRENT VS TTM AVG

-7.61%

CURRENT VS 3Y AVG

+6.51%

CURRENT VS 5Y AVG

+11.51%

CURRENT VS 10Y AVG

+12.52%

CURRENT VS 15Y AVG

+7.66%

CURRENT VS 20Y AVG

+3.71%

WST Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B1.80%1.95%1.69%1.61%
Waters Corporation (WAT)vs ›$24.41B0.86%2.74%2.65%2.68%
Mettler-Toledo International Inc. (MTD)vs ›$25.54B3.10%3.20%3.25%2.89%
Quest Diagnostics Incorporated (DGX)vs ›$23.23B5.64%6.22%5.63%7.18%
BioNTech SE (BNTX)vs ›$23.07B6.48%4.20%18.34%19.64%
United Therapeutics Corporation (UTHR)vs ›$23.03B3.97%5.14%5.77%5.80%
Moderna, Inc. (MRNA)vs ›$26.69BN/A8.49%9.09%9.09%
Incyte Corporation (INCY)vs ›$22.73B6.17%5.88%4.29%4.08%
DexCom, Inc. (DXCM)vs ›$27.07B5.18%3.47%2.14%1.45%
Labcorp Holdings Inc. (LH)vs ›$22.26B6.15%5.82%5.23%7.14%

Yield Comparison

FCF Yield

1.80%

Earnings Yield

2.13%

Dividend Yield

0.25%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Free Cash Flow Yield FAQ

What is the free cash flow yield for West Pharmaceutical Services, Inc. (WST)?
The free cash flow yield for WST stock is 1.80%.
Is West Pharmaceutical Services, Inc.'s free cash flow yield high or low?
The free cash flow yield of 1.80% is 11% above its 5-year average of 1.62%, around the middle of its 5-year range (0.81%–2.79%).
What is the TTM average free cash flow yield for West Pharmaceutical Services, Inc. (WST)?
The TTM average free cash flow yield for WST stock is 1.95%.
What is the 3Y average free cash flow yield for West Pharmaceutical Services, Inc. (WST)?
The 3Y average free cash flow yield for WST stock is 1.69%.
What is the 5Y average free cash flow yield for West Pharmaceutical Services, Inc. (WST)?
The 5Y average free cash flow yield for WST stock is 1.61%.
What is the 10Y average free cash flow yield for West Pharmaceutical Services, Inc. (WST)?
The 10Y average free cash flow yield for WST stock is 1.60%.
What is the 15Y average free cash flow yield for West Pharmaceutical Services, Inc. (WST)?
The 15Y average free cash flow yield for WST stock is 1.67%.
What is the 20Y average free cash flow yield for West Pharmaceutical Services, Inc. (WST)?
The 20Y average free cash flow yield for WST stock is 1.74%.

WST Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-261.80%
2026-06-251.83%
2026-06-241.86%
2026-06-231.88%
2026-06-221.92%
2026-06-181.93%
2026-06-171.96%
2026-06-161.92%
2026-06-151.91%
2026-06-121.92%
2026-06-111.91%
2026-06-101.91%
2026-06-091.89%
2026-06-081.98%
2026-06-052.01%
2026-06-041.99%
2026-06-032.00%
2026-06-022.03%
2026-06-012.00%
2026-05-291.96%
2026-05-281.97%
2026-05-272.02%
2026-05-262.00%
2026-05-222.00%
2026-05-212.00%
2026-05-202.07%
2026-05-192.08%
2026-05-182.08%
2026-05-152.09%
2026-05-142.11%
2026-05-132.09%
2026-05-122.03%
2026-05-111.96%
2026-05-081.94%
2026-05-071.96%
2026-05-062.02%
2026-05-052.04%
2026-05-042.11%
2026-05-012.10%
2026-04-302.13%
2026-04-292.14%
2026-04-282.17%
2026-04-272.09%
2026-04-242.07%
2026-04-232.04%
2026-04-222.35%
2026-04-212.35%
2026-04-202.32%
2026-04-172.36%
2026-04-162.39%
2026-04-152.42%
2026-04-142.41%
2026-04-132.48%
2026-04-102.51%
2026-04-092.49%
2026-04-082.43%
2026-04-072.49%
2026-04-062.51%
2026-04-022.53%
2026-04-012.55%
2026-03-312.57%
2026-03-302.63%
2026-03-272.65%
2026-03-262.60%
2026-03-252.61%
2026-03-242.63%
2026-03-232.67%
2026-03-202.72%
2026-03-192.68%
2026-03-182.70%
2026-03-172.69%
2026-03-162.68%
2026-03-132.74%
2026-03-122.79%
2026-03-112.71%
2026-03-102.76%
2026-03-092.60%
2026-03-062.62%
2026-03-052.64%
2026-03-042.59%
2026-03-032.57%
2026-03-022.57%
2026-02-272.54%
2026-02-262.59%
2026-02-252.60%
2026-02-242.63%
2026-02-232.64%
2026-02-202.68%
2026-02-192.65%
2026-02-182.60%
2026-02-172.65%
2026-02-132.08%
2026-02-122.14%
2026-02-112.12%
2026-02-102.14%
2026-02-092.09%
2026-02-062.09%
2026-02-052.25%
2026-02-042.20%
2026-02-032.26%
2026-02-022.20%
2026-01-302.26%
2026-01-292.24%
2026-01-282.21%
2026-01-272.17%
2026-01-262.16%
2026-01-232.20%
2026-01-222.10%
2026-01-212.04%
2026-01-202.08%
2026-01-162.01%
2026-01-151.87%
2026-01-141.90%
2026-01-131.92%
2026-01-121.91%
2026-01-091.89%
2026-01-081.89%
2026-01-071.87%
2026-01-061.86%
2026-01-051.87%
2026-01-021.89%
2025-12-311.90%
2025-12-301.88%
2025-12-291.89%
2025-12-261.90%
2025-12-241.88%
2025-12-231.88%
2025-12-221.90%
2025-12-191.91%
2025-12-181.94%
2025-12-171.94%
2025-12-161.96%
2025-12-151.92%
2025-12-121.95%
2025-12-111.91%
2025-12-101.95%
2025-12-091.96%
2025-12-081.94%
2025-12-051.86%
2025-12-041.85%
2025-12-031.83%
2025-12-021.91%
2025-12-011.90%
2025-11-281.88%
2025-11-261.88%
2025-11-251.86%
2025-11-241.90%
2025-11-211.92%
2025-11-202.02%
2025-11-192.02%
2025-11-182.00%
2025-11-171.99%
2025-11-142.00%
2025-11-131.96%
2025-11-121.90%
2025-11-111.88%
2025-11-101.89%
2025-11-071.92%
2025-11-061.89%
2025-11-051.84%
2025-11-041.82%
2025-11-031.86%
2025-10-311.85%
2025-10-301.87%
2025-10-291.83%
2025-10-281.84%
2025-10-271.82%
2025-10-241.75%
2025-10-231.70%
2025-10-221.71%
2025-10-211.69%
2025-10-201.72%
2025-10-171.75%
2025-10-161.77%
2025-10-151.80%
2025-10-141.81%
2025-10-131.80%
2025-10-101.81%
2025-10-091.79%
2025-10-081.76%
2025-10-071.78%
2025-10-061.76%
2025-10-031.73%
2025-10-021.73%
2025-10-011.74%
2025-09-301.80%
2025-09-291.82%
2025-09-261.81%
2025-09-251.86%
2025-09-241.82%
2025-09-231.88%
2025-09-221.87%
2025-09-191.85%
2025-09-181.85%
2025-09-171.84%
2025-09-161.83%
2025-09-151.83%
2025-09-121.86%
2025-09-111.79%
2025-09-101.85%
2025-09-091.87%
2025-09-081.87%
2025-09-051.88%
2025-09-041.91%
2025-09-031.90%
2025-09-021.94%
2025-08-291.91%
2025-08-281.93%
2025-08-271.92%
2025-08-261.93%
2025-08-251.91%
2025-08-221.91%
2025-08-211.95%
2025-08-201.92%
2025-08-191.91%
2025-08-181.94%
2025-08-151.92%
2025-08-141.92%
2025-08-131.92%
2025-08-121.97%
2025-08-111.97%
2025-08-081.96%
2025-08-071.96%
2025-08-061.99%
2025-08-051.98%
2025-08-041.98%
2025-08-011.98%
2025-07-311.98%
2025-07-301.90%
2025-07-291.87%
2025-07-281.83%
2025-07-251.79%
2025-07-241.69%
2025-07-231.85%
2025-07-221.92%
2025-07-212.00%
2025-07-181.99%
2025-07-171.90%
2025-07-161.87%
2025-07-151.90%
2025-07-141.87%
2025-07-111.85%
2025-07-101.83%
2025-07-091.86%
2025-07-081.91%
2025-07-071.90%
2025-07-031.89%
2025-07-021.90%
2025-07-011.89%
2025-06-301.92%
2025-06-271.92%
2025-06-261.92%
2025-06-251.90%
2025-06-241.89%
2025-06-231.94%
2025-06-201.95%
2025-06-181.93%
2025-06-171.93%
2025-06-161.87%
2025-06-131.89%

Showing the most recent 260 of 4,526 data points. The chart above shows the full history.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green